JAZZ vs. HRMY: Which Neuroscience Drugmaker Is the Stronger Play? [Yahoo! Finance]
Jazz Pharmaceuticals plc - Ordinary Shares (JAZZ)
Last jazz pharmaceuticals plc - ordinary shares earnings: 2/25 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
jazzpharma.com
Company Research
Source: Yahoo! Finance
Jazz Pharmaceuticals markets multiple neuroscience drugs, including the blockbuster oral sleep disorder drug Xywav and the cannabidiol (CBD) drug Epidiolex. Harmony Biosciences has only one marketed drug in its portfolio, Wakix (pitolisant), which is approved to treat excessive daytime sleepiness (EDS) or cataplexy in narcolepsy patients. Both companies are experiencing consistent sales and earnings growth. But, which one makes for a better investment pick today? Let's examine the fundamentals of the two stocks closely to make a prudent choice. Jazz derives more than two-thirds of its total revenues from its neuroscience franchise. Xywav is approved to treat three conditions, including cataplexy and EDS in narcolepsy patients. Being a low-sodium formulation, this drug also does not carry warnings and precautions related to high sodium intake, which currently makes it the only approved oxybate therapy to do so. Xywav is also the only FDA-approved treatment for the full spectru
Show less
Read more
Impact Snapshot
Event Time:
JAZZ
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
JAZZ alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
JAZZ alerts
High impacting Jazz Pharmaceuticals plc - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
JAZZ
News
- Is It Too Late To Consider Jazz Pharmaceuticals After Its Strong 2024 Share Price Rally? [Yahoo! Finance]Yahoo! Finance
- Jazz Pharmaceuticals to Participate in Upcoming Investor Events [Yahoo! Finance]Yahoo! Finance
- Jazz Pharmaceuticals to Participate in Upcoming Investor EventsPR Newswire
- Jazz Pharmaceuticals to Participate in Upcoming Investor EventsPR Newswire
- 3 Value Stocks We're Skeptical Of [Yahoo! Finance]Yahoo! Finance
JAZZ
Earnings
- 11/5/25 - Beat
JAZZ
Sec Filings
- 12/11/25 - Form 4
- 12/10/25 - Form 3
- 12/9/25 - Form 144
- JAZZ's page on the SEC website